BILL vs Tipalti for Dental Support Organizations

Supply reorders are frequent, relatively predictable and low-risk individually; a missed reorder just means calling the distributor again. Lab fees are less frequent per office but carry more scrutiny, since they're tied to specific patient cases and sometimes insurance documentation. Building one undifferentiated approval process for both usually means supply orders get held up by scrutiny they don't need, or lab invoices get rubber-stamped without the case-level check they actually benefit from.

Many DSOs give each office manager or clinical lead a standing purchase authority up to a set dollar amount for routine supply reorders, with anything above that threshold requiring DSO-level approval. BILL supports this cleanly with role-based approval limits tied to each location, and it's the lower-setup option if your supply vendor base is a small, stable list of national dental distributors that every location orders from.

Larger DSOs sometimes centralize all supply purchasing through a single buyer who negotiates volume pricing across every location and places all the orders directly, with individual offices submitting requests rather than ordering themselves. This approach gets more value from Tipalti if your vendor base includes lab partners or specialty suppliers billing across multiple locations under one relationship, since Tipalti's structure handles that kind of consolidated, multi-location vendor relationship more naturally than a location-by-location model does.

Dental lab invoices, crowns, dentures, orthodontic appliances, are typically billed per case rather than on a standard PO, and matching a lab invoice back to the specific patient case and treating dentist matters for both cost tracking and occasionally for insurance documentation. Neither BILL nor Tipalti has a native concept of a case-level match; that linkage needs to happen in your practice management software, with the AP platform used only to execute the actual payment once a lab invoice has been reviewed against expected case volume.

Payables across healthcare support services businesses run longer than most other sectors, averaging around 51.5 days¹, which reflects how much of this category's spend flows through insurance-adjacent billing cycles rather than straightforward vendor terms. A DSO that pays its supply and lab vendors noticeably faster than that baseline is likely leaving early-pay discount discount opportunities on the table; one paying much slower risks straining vendor relationships that matter during supply shortages.

A five-location DSO with decentralized ordering and a twelve-location DSO with centralized purchasing have different payables needs despite the location count suggesting otherwise. If your offices order independently within set limits, BILL's role-based approval structure fits well at almost any location count. If you're centralizing purchasing and negotiating consolidated vendor relationships across locations, Tipalti's structure supports that model more naturally, regardless of whether you're at five locations or twenty. Either way, the purchasing model should drive the platform choice, not the other way around; picking a platform first and then forcing your purchasing structure to fit it tends to create friction that shows up as clinical staff frustration months later.

Whichever model you choose, run a spot check partway through rollout: pull a sample of recent supply orders from two or three offices and confirm they cleared at the approval level you intended, not one office's manager quietly getting escalation authority they shouldn't have, and not another office hitting unnecessary friction on routine reorders. Clinical staff notice fast when a supply order is delayed, and a DSO that loses office-level trust in the new process early has a harder time getting full adoption later.

Checks to run partway through rollout:

• Pull a sample of recent supply orders from two or three offices and confirm each cleared at the approval level you intended.
• Make sure no office manager has quietly gained escalation authority they should not have.
• Confirm lab invoices are matched to patient cases in your practice management software, since neither platform does that.
• Budget real time to reconcile acquired locations' vendor relationships and approval habits onto your standard setup.

A DSO that grows partly by acquiring existing practices inherits each practice's existing vendor relationships, payment terms and sometimes its own approval habits, which rarely match cleanly across a newly combined group. Budget real time for reconciling acquired locations onto your standard vendor list and approval structure rather than assuming a newly acquired office will simply adopt the DSO's existing setup on day one; that transition is usually the messiest part of scaling a multi-location dental group's payables, more than the platform choice itself.